Last Updated on January 9, 2024 by The Health Master
The Union commerce ministry has recommended imposition of anti-dumping duty on dicyclohexylcarbodiimide (DCC) imported from China for five years to guard domestic industry from cheap imports.
DCC is widely used in medical, health, make-up and biological products. It is a key raw material in antiretroviral drugs like valaliclovir and amikacin.
This product is mainly used in amikacin, glutathione dehydrants, as well as in the synthesis of acid anhydride, aldehyde, ketone, and isocyanate. It is also used in the synthesis of peptides, esters, ethers, nitriles etc.
The commerce ministry’s investigation arm Directorate General of Trade Remedies (DGTR) has initiated a probe into an alleged dumping of DCC from China following a complaint filed by Clean Science and Technology Pvt Ltd.
The applicant has alleged that material injury is being caused to the domestic industry due to dumped imports from the subject country and has requested for the imposition of the anti-dumping duties on the imports.
The applicant, being the first and the only producer of DCC declared commercial production in November, 2019, but commenced commercial production only in January, 2020. It holds 100 per cent share in the total domestic production of DCC in India.
Prior to the domestic industry’s entry into the market, the price of DCC, which was imported from China was Rs. 1,117/kg. The prices of the imported DCC decreased after it commenced commercial production.
There is clear indication that the producers are engaging in predatory pricing, and their intention is to drive the domestic industry out of the market, stated the applicant.
The applicant claimed that an increase in imports of DCC from China at a price below selling price has adversely impacted production, sales and profits of domestic industry.
With respect to the claim of the domestic industry that the prices of the imported DCC declined after it started manufacturing the product, DGTR has examined the same and has conducted a detailed injury analysis.
The period of investigation was January 1, 2020 to December 31, 2020, including data from April 2017 onwards.
During the probe, the directorate found that the dumping of DCC has materially retarded the establishment of domestic industry in India.
“The imports are priced below the target prices of the domestic industry leading to price suppression. The domestic industry has not been able to produce the product to the extent it could have produced.
Further, despite significant demand for the product in the country, the domestic industry has not been able to sell even to the limited extent it has produced, and has been faced with significant inventories.
The domestic industry is suffering significant financial losses and negative return on investment,” stated DGTR findings.
In a notification on February 24, 2022, the authority said there is a likelihood of continuation of dumping of DCC from China and injury to domestic players if anti-dumping duty is not imposed.
It recommended imposition of anti-dumping duty on import of the product from China for five years. The recommended duty ranges between US$ 493.73 per metric tonne and US$ 826.75 per metric tonne.
The final decision on imposing the duty will be taken by the finance ministry. The aim of duty is to ensure fair trade practices and create a level-playing field for domestic industry as against foreign manufacturers and exporters.
Govt releases draft Unani Pharmacopoeia of India
USFDA declines pediatric EUA for vaccine Covaxin
NPPA cancels study access of medicine at affordable prices
WHO updates its treatment guidelines to include Molnupiravir
USFDA gives nod to Lupin for generic Jublia topical solution
Govt listed 213 drugs for which procurement agencies could not find local manufacturers
USFDA gives nod to Lupin for Sevelamer Hydrochloride Tablets, 800 mg
USFDA declines to approve Gilead’s HIV drug on this concern
Why these Pharma Companies are realigning their India operations
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
